NYSE:DHR - Danaher Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $274.14
  • Forecasted Upside: 2.54 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$267.35
▼ -1.09 (-0.41%)

This chart shows the closing price for DHR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Danaher Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DHR

Analyst Price Target is $274.14
▲ +2.54% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $274.14, with a high forecast of $315.00 and a low forecast of $210.00. The average price target represents a 2.54% upside from the last price of $267.35.

This chart shows the closing price for DHR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 13 investment analysts is to buy stock in Danaher. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/18/2021Credit Suisse GroupBoost Price TargetOutperform$282.00 ➝ $288.00Low
4/26/2021William BlairReiterated RatingOutperformLow
4/26/2021BarclaysBoost Price TargetOverweight$265.00 ➝ $300.00Low
4/23/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$275.00 ➝ $315.00Low
4/23/2021CitigroupBoost Price Target$275.00 ➝ $315.00Low
4/23/2021KeyCorpBoost Price TargetOverweight$280.00 ➝ $315.00High
4/23/2021Jefferies Financial GroupBoost Price TargetBuy$270.00 ➝ $290.00High
4/23/2021Robert W. BairdBoost Price TargetOutperform$249.00 ➝ $270.00High
4/23/2021Wells Fargo & CompanyBoost Price TargetOverweight$260.00 ➝ $280.00High
4/23/2021Royal Bank of CanadaBoost Price TargetSector Perform$253.00 ➝ $285.00High
3/8/2021BarclaysInitiated CoverageOverweight$260.00N/A
3/2/2021BarclaysInitiated CoverageOverweight$260.00Medium
1/14/2021Credit Suisse GroupBoost Price TargetOutperform$260.00 ➝ $264.00Low
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$250.00Low
11/25/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$273.00 ➝ $234.00Low
11/9/2020KeyCorpInitiated CoverageOverweight$280.00High
10/27/2020Needham & Company LLCBoost Price Target$209.00 ➝ $272.00Low
10/23/2020Royal Bank of CanadaBoost Price TargetOutperform$250.00 ➝ $273.00Medium
10/23/2020Robert W. BairdBoost Price TargetOutperform$205.00 ➝ $252.00Medium
9/29/2020Wells Fargo & CompanyReiterated RatingBuy$234.00Low
7/27/2020Needham & Company LLCBoost Price TargetBuy$183.00 ➝ $209.00Low
7/27/2020UBS GroupBoost Price TargetBuy$176.00 ➝ $233.00Low
7/24/2020Stifel NicolausBoost Price TargetHold$170.00 ➝ $210.00Low
7/24/2020Jefferies Financial GroupBoost Price TargetBuy$190.00 ➝ $230.00Low
7/24/2020Robert W. BairdBoost Price TargetOutperform$163.00 ➝ $205.00Medium
7/24/2020Royal Bank of CanadaBoost Price TargetOutperform$205.00 ➝ $218.00Medium
7/20/2020Bank of AmericaBoost Price TargetBuy$181.00 ➝ $215.00Low
7/20/2020Royal Bank of CanadaReiterated RatingBuy$205.00Low
6/16/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$195.00Low
5/21/2020Credit Suisse GroupBoost Price TargetOutperform$165.00 ➝ $169.00Low
5/15/2020Needham & Company LLCLower Price TargetBuy$187.00 ➝ $183.00High
5/11/2020Royal Bank of CanadaBoost Price TargetIn-Line ➝ Outperform$159.00 ➝ $173.00Low
5/8/2020Stifel NicolausBoost Price TargetHold$147.00 ➝ $170.00Low
5/8/2020CitigroupBoost Price TargetBuy$180.00 ➝ $190.00High
5/7/2020Bank of AmericaBoost Price TargetBuy$160.00 ➝ $181.00Medium
4/21/2020Wells Fargo & CompanyBoost Price TargetOverweight$155.00 ➝ $170.00Medium
4/20/2020CitigroupBoost Price TargetBuy$160.00 ➝ $180.00Low
4/2/2020Stifel NicolausLower Price TargetHold$162.00 ➝ $147.00Medium
4/2/2020Wolfe ResearchDowngradeOutperform ➝ Market Perform$154.00High
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$176.00 ➝ $155.00Medium
3/26/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformLow
3/25/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$151.00 ➝ $157.00High
3/23/2020Robert W. BairdReiterated RatingBuy$136.00High
3/20/2020CitigroupLower Price TargetBuy$195.00 ➝ $160.00Medium
2/3/2020CowenReiterated RatingBuy$170.00High
2/3/2020Needham & Company LLCBoost Price TargetBuy$167.00 ➝ $187.00Low
1/31/2020Bank of AmericaBoost Price TargetBuy$165.00 ➝ $188.00Low
1/31/2020Robert W. BairdBoost Price TargetOutperform$160.00 ➝ $175.00High
1/31/2020Stifel NicolausBoost Price TargetHold$150.00 ➝ $162.00High
1/31/2020CitigroupBoost Price TargetBuy$180.00 ➝ $195.00High
1/30/2020Piper SandlerBoost Price Target$142.00 ➝ $174.00High
1/10/2020UBS GroupBoost Price TargetNeutral$165.00 ➝ $176.00Low
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$170.00Low
1/6/2020CitigroupInitiated CoverageBuy$180.00Low
1/2/2020Needham & Company LLCBoost Price TargetBuy$152.00 ➝ $167.00Low
12/19/2019JPMorgan Chase & Co.Boost Price Target$155.00 ➝ $175.00Medium
12/19/2019Credit Suisse GroupBoost Price TargetOutperform$151.00 ➝ $160.00Low
12/18/2019Royal Bank of CanadaReiterated RatingHold$145.00Medium
12/2/2019UBS GroupBoost Price TargetBuy$158.00 ➝ $165.00Low
11/14/2019Stifel NicolausReiterated RatingHold$150.00High
10/28/2019Needham & Company LLCLower Price TargetBuy$155.00 ➝ $152.00Low
10/25/2019Wolfe ResearchSet Price TargetBuy$154.00N/A
10/14/2019Credit Suisse GroupReiterated RatingOutperform$151.00Low
9/26/2019Wolfe ResearchSet Price TargetBuy$157.00Medium
7/23/2019ArgusBoost Price TargetBuy$165.00Low
7/19/2019Royal Bank of CanadaSet Price TargetHold$134.00Low
7/19/2019Robert W. BairdBoost Price TargetOutperform$131.00 ➝ $148.00Low
7/19/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$142.00 ➝ $155.00Low
7/18/2019Piper Jaffray CompaniesBoost Price TargetNeutral$148.00 ➝ $153.00Low
6/11/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$148.00Low
5/30/2019Wolfe ResearchInitiated CoverageOutperform ➝ OutperformMedium
4/17/2019Janney Montgomery ScottBoost Price TargetBuy$136.00 ➝ $174.00Medium
4/17/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$138.00 ➝ $141.00High
3/4/2019JPMorgan Chase & Co.Reiterated RatingOverweight$140.00Medium
2/28/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$114.00 ➝ $138.00Low
2/26/2019Jefferies Financial GroupBoost Price TargetBuy$140.00Medium
2/26/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$130.00Medium
2/26/2019UBS GroupBoost Price TargetBuy$125.00 ➝ $144.00Medium
2/25/2019Janney Montgomery ScottUpgradeNeutral ➝ BuyHigh
1/7/2019CowenReiterated RatingBuy$110.00Low
1/2/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$114.00High
12/19/2018Royal Bank of CanadaReiterated RatingHold$102.00High
10/19/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$116.00 ➝ $114.00Medium
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$122.00 ➝ $126.00High
7/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $122.00Medium
7/19/2018Royal Bank of CanadaBoost Price TargetSector Perform ➝ Positive$107.00Medium
7/19/2018Bank of AmericaSet Price TargetBuy$113.00Medium
7/13/2018Morgan StanleyBoost Price TargetOverweight$113.00 ➝ $120.00Low
4/20/2018BarclaysReiterated RatingBuy$113.00Low
4/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$112.00 ➝ $113.00Low
4/20/2018Jefferies Financial GroupReiterated RatingBuy$117.00Low
4/20/2018Robert W. BairdReiterated RatingBuy$106.00Low
4/19/2018Stifel NicolausReiterated RatingBuy ➝ Buy$108.00 ➝ $114.00Low
4/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$110.00 ➝ $112.00Low
3/13/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$106.00 ➝ $108.00Low
3/9/2018Credit Suisse GroupReiterated RatingHold ➝ OutperformLow
3/1/2018Deutsche Bank AktiengesellschaftLower Price TargetBuy ➝ Buy$114.00 ➝ $107.00Low
2/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$110.00Low
2/1/2018ArgusBoost Price TargetBuy$100.00 ➝ $115.00Low
1/31/2018Royal Bank of CanadaReiterated RatingHold$98.00Low
1/31/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$110.00 ➝ $115.00Low
1/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$103.00 ➝ $110.00Low
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$99.00 ➝ $105.00Low
1/30/2018CowenReiterated RatingBuy$110.00Low
1/22/2018UBS GroupInitiated CoverageBuy$116.00 ➝ $99.97Low
1/19/2018Stifel NicolausReiterated RatingBuy$110.00Low
1/12/2018Robert W. BairdReiterated RatingBuyLow
1/4/2018Royal Bank of CanadaReiterated RatingHold$96.00Low
1/3/2018Evercore ISIInitiated CoverageOutperformLow
12/19/2017Credit Suisse GroupReiterated RatingHold$99.00Low
12/15/2017Robert W. BairdReiterated RatingBuy$99.00Low
12/15/2017CitigroupBoost Price TargetBuy$107.00High
10/20/2017Robert W. BairdBoost Price TargetOutperform$87.00 ➝ $97.00N/A
10/20/2017Credit Suisse GroupBoost Price TargetOutperform$93.00 ➝ $96.00N/A
10/20/2017Morgan StanleyBoost Price TargetOverweight$95.00 ➝ $98.00N/A
10/6/2017Morgan StanleyReiterated RatingOverweight$86.00 ➝ $95.00N/A
10/4/2017CowenReiterated RatingBuy$90.00Low
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$83.00Low
9/8/2017JPMorgan Chase & Co.Reiterated RatingOverweight$95.00Low
8/4/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
7/22/2017Wells Fargo & CompanyReiterated RatingMarket PerformLow
7/21/2017CitigroupSet Price TargetBuy$98.00 ➝ $96.00Low
7/13/2017Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market Perform$90.00Medium
7/12/2017Royal Bank of CanadaReiterated RatingHold$88.00Low
6/21/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$97.00Low
6/7/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralLow
5/24/2017Credit Suisse GroupReiterated RatingBuy$93.00Low
4/23/2017William BlairReiterated RatingOutperformLow
4/23/2017CowenReiterated RatingOutperform$90.00Low
4/23/2017BTIG ResearchReiterated RatingBuy$92.00Low
4/21/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$89.00 ➝ $88.00High
2/24/2017CitigroupUpgradeNeutral ➝ Buy$98.00N/A
2/1/2017Jefferies Financial GroupBoost Price TargetBuy$93.00 ➝ $95.00N/A
2/1/2017Credit Suisse GroupUpgradeNeutral ➝ Outperform$80.00 ➝ $93.00N/A
1/31/2017Evercore ISIBoost Price TargetBuy$88.50 ➝ $91.50N/A
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$88.00N/A
1/2/2017Royal Bank of CanadaSet Price TargetHold$84.00N/A
12/15/2016Sanford C. BernsteinReiterated RatingOutperformN/A
12/13/2016Morgan StanleyReiterated RatingOverweightN/A
11/11/2016CowenUpgradeMarket Perform ➝ Outperform$95.00N/A
10/21/2016Royal Bank of CanadaSet Price TargetHold$85.00 ➝ $86.00N/A
10/12/2016Evercore ISIReiterated RatingBuy$89.00N/A
10/6/2016JPMorgan Chase & Co.Reiterated RatingBuy$90.00N/A
9/8/2016Jefferies Financial GroupReiterated RatingBuyN/A
9/7/2016BarclaysBoost Price TargetOverweight$90.00 ➝ $91.00N/A
8/31/2016Morgan StanleyReiterated RatingBuy$86.00N/A
8/2/2016CitigroupReiterated RatingMarket Perform$85.00N/A
8/2/2016CowenInitiated CoverageMarket PerformN/A
7/28/2016ArgusReiterated RatingBuy$110.00 ➝ $90.00N/A
7/27/2016BarclaysReiterated RatingOverweight$90.00N/A
7/27/2016CitigroupBoost Price TargetNeutral$81.00 ➝ $84.00N/A
7/26/2016Jefferies Financial GroupBoost Price TargetBuy$92.00 ➝ $93.00N/A
7/25/2016Credit Suisse GroupReiterated RatingHoldN/A
7/15/2016UBS GroupReiterated RatingBuy$108.00 ➝ $92.00N/A
7/15/2016Jefferies Financial GroupReiterated RatingBuy$105.00 ➝ $92.00N/A
7/12/2016JPMorgan Chase & Co.Initiated CoverageNeutralN/A
7/11/2016BarclaysReiterated RatingOverweight$105.00 ➝ $86.00N/A
7/9/2016Credit Suisse GroupReiterated RatingHoldN/A
7/5/2016CitigroupReiterated RatingNeutralN/A
7/5/2016The Goldman Sachs GroupInitiated CoverageNeutral$74.00N/A
6/30/2016JPMorgan Chase & Co.Reiterated RatingBuy$105.00N/A
6/27/2016BarclaysReiterated RatingOverweight$105.00N/A
(Data available from 6/24/2016 forward)
Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Read More

Today's Range

Now: $267.35
Low: $265.13
High: $270.63

50 Day Range

MA: $252.44
Low: $240.20
High: $268.65

52 Week Range

Now: $267.35
Low: $168.59
High: $270.63

Volume

3,129,288 shs

Average Volume

2,606,204 shs

Market Capitalization

$190.70 billion

P/E Ratio

42.10

Dividend Yield

0.31%

Beta

0.69

Frequently Asked Questions

What sell-side analysts currently cover shares of Danaher?

The following equities research analysts have issued reports on Danaher in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Jefferies Financial Group Inc., KeyCorp, Needham & Company LLC, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, The Goldman Sachs Group, Inc., UBS Group AG, Wells Fargo & Company, William Blair, and Zacks Investment Research.
View the latest analyst ratings for DHR.

What is the current price target for Danaher?

14 Wall Street analysts have set twelve-month price targets for Danaher in the last year. Their average twelve-month price target is $274.14, suggesting a possible upside of 2.0%. KeyCorp has the highest price target set, predicting DHR will reach $315.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $210.00 for Danaher in the next year.
View the latest price targets for DHR.

What is the current consensus analyst rating for Danaher?

Danaher currently has 2 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DHR will outperform the market and that investors should add to their positions of Danaher.
View the latest ratings for DHR.

What other companies compete with Danaher?

How do I contact Danaher's investor relations team?

Danaher's physical mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate's listed phone number is 202-828-0850 and its investor relations email address is [email protected] The official website for Danaher is www.danaher.com.